Tuberculosis Screening Gaps Persist in New DMARD Users : vim

Substantial patient safety gaps regarding latent tuberculosis screening persist among new users of biologic or targeted synthetic DMARDs, suggested a nationwide cohort study.

Related Keywords

California , United States , San Francisco , Erict Roberts , , University Of California , Arthritis Care Research , Hispanic White , Arthritis Care , Biologic Therapy , Iologics , Tuberculosis Tb , Disease Modifying Antirheumatic Drugs , Sdmards , Simard , Rheumatoid Arthritis Ra , Heumatoid Arthritis Ra , Arthritis , Oint Inflammation , Medicare , Preventive Screening , Screening , Patient Safety , A Scan Biometry , A Scan Ultrasound Biometry , Ea Scan , Clinical Guidelines , Guidelines ,